clinical trial · NCT05753189
Phase 3 Safety Study for the Treatment of Presbyopia Subjects
PresbyopiaNear VisionMiosisEye DiseasesAceclidine+Brimonidine combination ophthalmic solutionPlaceboAceclidine Ophthalmic Solution
brief summary
Safety Study of the Long-Term Safety of LNZ101 in Presbyopic Subjects
started
Feb 21, 2023
primary completion
Feb 9, 2024
completion
Feb 9, 2024
last updated
Dec 18, 2024
detailed description
Safety Study: Multi-Center, Double-Masked Phase 3 Evaluation of the Long-Term Safety of LNZ101 in Presbyopic Subjects
official title
Safety Study: A Multi-Center, Double-Masked Phase 3 Safety Study Evaluation of the Long-Term Safety of LNZ101 in Presbyopic Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol